1. Mintz M. At Any Cost: Corporate Greed, Women, and the Dalkon Shield. New York: Pantheon, 1985.

2. Hicks K. Surviving the Dalkon Shield IUD: Women v. the Pharmaceutical Industry. New York: Teachers College Press, 1994.

3. Mundy A. Dispensing with the Truth: The Victims, the Drug Companies, and the Dramatic Story behind the Battle over Fen-Phen. New York: St. Martin’s Press, 2001.

4. Marshall E. Buried data can be hazardous to a company’s health. Science. 2004;304:1576–77.

5. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. NEJM 2007;356:
2457–71.

6. Psaty BM, Furberg CD. Rosiglitazone and cardiovascular risk. NEJM 2007;356:2522–4.

7. Vernick JS, Mair JS, Teret SP et al. Role of litigation in preventing product-related injuries. Epidemiol Rev. 2003;25(1):90–98.

8. Transportation Recall Enhancement, Accountability, and Documentation (TREAD) Act. Public law no. 106– 414, November 1, 2000.

9. Public Citizen, Safetyforum.com. The real root cause of the Ford-Firestone tragedy: Why the public is still at risk. April 2001. Available at: http://www.citizen.org/documents/rootcause.pdf. Accessed in June 2007.

10. Conrad JW Jr. Open secrets: The widespread availability of information about the health and environmental effects of chemicals. Law and Contemporary Problems. 2006;69(3):141–65.

11. Givelber DJ, Robbins A. Public health vs. court-sponsored secrecy. Law and Contemporary Problems. 2006;69(3):131–39.

12. Felcher EM. It’s No Accident: How Corporations Sell Dangerous Baby Products. Monroe, ME, and Philadelphia, PA: Common Courage Press, 2001.

13. Anderson JS. Hidden from the public by order of the court: The case against government-enforced secrecy. SC Law Rev. 2004;55:711–59.

14. Casey M. OSHA: Discounted lives. Kansas City Star. December 11, 2005:A1.

15. Barab J. Kansas City Star clobbers OSHA. Confined Space Blog. December 12, 2005. Available at: http://spewingforth.blogspot.com/2005/12/kansascity-star-clobbers-osha.html. Accessed in June 2007.

16. Barab J. What’s more effective? OSHA penalties or suing the bastards? Confined Space Blog. February 2, 2006. Available at: http://spewingforth.blogspot.com/2006/02/whats-more-effective-osha-penalties-or.html. Accessed
in June 2007.

17. Vladeck DC. Federal preemptions of state tort law: The problem of medical drugs and devices: Preemption and regulatory failure. Pepp L Rev. 2005;33:95–131.

18. Levin M, Miller AC. Industries get quiet protection from lawsuits. Los Angeles Times. February 19, 2006.

19. Sharkey CM. Preemption by preamble: Federal agencies and the federalization of tort reform. DePaul Law Review. 2007;56.

20. Associated Press. Vioxx judge finds FDA approval of drug label doesn’t avert claims. Wall Street Journal (online). July 3, 2007.

21. Tesoriero HW. Merck’s Vioxx troubles may ebb with ruling poised to aid defense. Wall Street Journal. April 13, 2007:A3.